Benztropine Mesylate Injection
Product Images NDC 68475-512

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Benztropine Mesylate (NDC 68475-512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Navinta Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Benztropine-fig-01 (69c6013b C977 409a B03b 1ecd473e6846 01)

Chemical structure of Benztropine Mesylate, showing its bicyclic amine core attached to a diphenylmethoxy group and a mesylate moiety.*

FDA Label Image

Image-3 (69c6013b C977 409a B03b 1ecd473e6846 02)

Label for Benztropine Mesylate Injection, USP containing 2 mg per 2 mL (1 mg/mL) solution. It is manufactured by Navinta LLC, Ewing, NJ. The label specifies use for intravenous or intramuscular injection and indicates a 2 mL single dose vial. Storage instructions and a barcode are also visible on the label.*

FDA Label Image

Impage-2 (69c6013b C977 409a B03b 1ecd473e6846 03)

Benztropine Mesylate Injection, USP 1 mg/mL (2 mg/2 mL) in a carton for intravenous or intramuscular use. The label states a package size of 5 single-dose 2 mL vials. Labeler is Navinta LLC. The box also lists inactive ingredients sodium chloride and water for injection, and includes dosage storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.